Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://smallcapstreet.com/xxii/
While its a nice little write-up (the same one that came out yesterday), I don't like "SCS LLC has been compensated ten thousand dollars cash via bank wire by star media LLC for a three day investor relations campaign of XXII."
Volume 1M in 17 minutes. I guess the rest of us will figure out what is causing the volume eventually. May be a record volume day?!
I guess those Christmas cards did the trick
B-Scada Software Used to Facilitate Eco-Friendly Electric Power in South Korea
Thursday, December 10, 2015
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has announced a recent deployment of their Status Enterprise software in South Korea for monitoring resources used in eco-friendly power plants. The customer, GS E&R Corp., is engaged in combined power plant management and renewable energy business, focusing on Central and Southeast Asia. In addition to renovation of outdated power generation facilities and construction of new facilities, they also design and implement energy saving and conservation projects.
Using B-Scada's platform, the customer will monitor remote sump pumps and ventilation fans using custom dashboards designed to their exact specifications. B-Scada's software solutions are deployed worldwide for a wide range of applications that are helping to improve efficiency, safety, and quality while reducing resource consumption and waste. GS E&R Corp. provides yet another example of how B-Scada is contributing to a cleaner, safer, more efficient world.
Thanks NKerf. I meant 4x (not 3x) but I interpreted "closing this account could more than quintuple the Company's 2015 revenues" as something written before SF deal and forward-looking for 2015. But I certainly hope you are correct and Atlanta isnt posting something from a year ago! That would be great news going into 2016.
Isn't this just a rehash from before Smoker Friendly partnership was announced? Its December 2015 now and this is talking about helping to triple 2015 revenue. Unless I'm misinterpreting the statement
re: Red Sun
I noticed a bunch of new locations in Maine.
http://www.redsuncigarettes.com/locations/
10-Q just came out.
Looks like rev of $380k vs $309k and swung to a 16k profit. No shares issued in 2015. Not quite the home run we were hoping for but certainly signs of improvement from last yr. The pr may shed some light on those big contracts AMPG is bidding on.
Not sure if we misinterpreted the commentary in that Oct newsletter or what. Interesting to note that the newsletter disappeared from Amplitech website after we discovered it. Its also possible that July and Aug were just really slow, and Sept was really strong? Anyway, from first glance, doesnt look like a bad report, just not as exciting as we were hoping for.
Possible additions:
Amplitech CEO previously founded and subsequently sold his Amplicomm business to Aeroflex ( http://www.thefreelibrary.com/Aeroflex+Incorporated+Announces+Acquisition+of+Amplicomm,+Inc.-a065517580 ). Aeroflex was recently sold for $920 million ( http://www.reuters.com/article/2014/05/20/us-cobham-aeroflex-idUSBREA4J0LY20140520#rfFF7vy4JzktabEj.97 )
Also, for what its worth, Microphase Corp, a 60 yr old company w/ $8M+ annual revenue, received a $300k equity investment in July 2014.
Nothing new here but written a few days ago (by a high ranking health official)
http://www.huffingtonpost.com/nora-volkow/new-study-shows-benefits-of-reducing-nicotine-in-cigarettes_b_8493780.html
That was quick "Some unknowns out there that make me think this could continue to fall to 1.30 or 1.25"
Quite a fall from 1.75 at the open
There was this comment in the last earnings pr:
"Mr. Maqbool added, "We are still in the process of evaluating the most favorable investment options from private investors and funds to boost our growth rate and overall valuation."
In order to be eligible for some of these large government contracts, Amplitech may have to show they are on solid financial ground by boasting their cash reserves? Hope they get/got the best possible terms, if this is necessary.
Yeah, the Form 4 is a non-event, as it was part of a trading plan, probably set up years ago. Moynihan has @ 1M shares left plus hundreds of thousands of options, so he has plenty of skin in the game.
'Rule 10b5-1' A rule established by the Securities Exchange Commission (SEC) that allows insiders of publicly traded corporations to set up a trading plan for selling stocks they own. Rule 10b5-1 allows major holders to sell a predetermined number of shares at a predetermined time."
"Green Sun" has a nice ring to it.
Yeah, not sure why I was thinking just Sept vs Sept. You are correct and it does sounds very bullish for a big revenue quarter. And it sounds like it may be sustainable due to the new approaches to selling the products.
Q3 in 2014 had $309k in revenue, but we don't have a month by month breakdown, so hard to know what they did in Sept last year to compare it w/ this yr's 50%+ increase. I hope it wasn't 20k. Haha.
$600k+ revenue would be nice, but again, still a lot of unknowns at this point. The commentary was quite upbeat and plenty of room for major upside if any one of this deals get done. I also like the fact that Microphase Corp is "in bed" with AMPG (after the financing), and Amplitech has big league customers like BEA Systems and L-3. Seems like there is potential for being acquired at some point. Not many stocks w/ this market cap have much going for them, so AMPG seems like an intelligent gamble. The Q should be interesting...
That's the way I read it and sounds bullish, assuming they ship orders as soon as they receive orders (and didnt ship August orders w/ Sept orders, or something funky like that).
Hopefully, the "invested heavily in marketing" doesnt harm profitability too much this Q. The potential for "several million dollar orders" with the govt. would be a game-changer for this stock, one would think, but I'm not going to bet the farm until I see it actually happen. But overall, seems like the lack of pr's doesnt equate to weakness at Amplitech. Looking forward to the Q.
Sept newsletter
"AmpliTech, Inc. has recently invested heavily into marketing to the U.S. goverment and is in the running for several million-dollar projects that, although to be announced in 2016, will be able to carry us through at least two quarters wherein the addtion of what we'd normally produce will be a bonus. Last time, we mentioned an expanded marketing base by cross-marketing items sold by our vendors while letting them sell our products. As such, we'll be able to sell our bread-and-butter LNAs along with High-Frequency millimeter-wave products along with Medium to High Power amplifiers, waveguides and even DROs to a much larger customer base while our partners will be selling our products to new and existing customers, thus potentially expanding our sales volume exponentially. RFQs are double what they were last year at this time and, with better reps working for us who can get target pricing and competitor information, our chances of winning any particular order has gone up about 40% since last year, especially in overseas markets.
The results of these various approaches has been immediately apparent as we've shipped over 50% in September than we did all of this quarter last year."
TECHNICAL CORNER...A WORD FROM OUR ENGINEERS
AmpliTech has found a way to minimize NRE costs for custom housings by using innovative circuit integration into housings other than our own. This has been a boon to customers requiring amplifiers with specific physical dimensions to fit into their systems and are either dissatisfied with their current vendor or simply want better performance. We can now provide our technically superior products in a custom housing WITHOUT thousands of dollars in NRE and even without NRE at all in some cases where production quantities are required "It's all about winning the customer, not just winning the order," said Chief Engineer Fawad Maqbool, "and this is one way in which we hope to do that."
http://amplitechinc.bmetrack.com/c/v?e=7FB292&c=23F8D&t=1&l=CD1FBF3&email=z8pKhtDfvaU%2F8K%2B80Wi2%2BFHG3QGCXckMNyIeD9VsXLU%3D&relid=
SCKT ($2.35) reports after the bell. Q3 is typically their strongest Q, followed by Q2 (which came in at 8 cents eps). They have a tough Q3 y/y comp of 9 cents eps, so we will see what they post this year. Their scanner growth has been gaining momentum and hopeful that continues as the mPOS industry grows.
As southacres as pointed out, costs are relatively fixed so increasing revenue can translate into impressive eps.
CC at 5 EST may provide some positive guidance for Q4/Q1 after announcing a large $1.6M somo order to be recognized in those seasonally slower Q's.
It would be great if B Scada could secure some "smart city" contracts. Seems like they have the potential to be quite large, as cities have a lot of things to monitor.
The company creates some nice, professional promo videos for marketing:
Agreed. Hoping that staying ahead of the curve and being relevant to customer's needs translates into more customer wins
B-Scada Announces Major Addition to Status Enterprise with Next Release
Tuesday, October 20, 2015
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has announced an exciting new addition to their popular SCADA platform, Status Enterprise. In early November, Status Enterprise 4.0 will ship with a number of new features and enhancements, including an all new CMMS (Computerized Maintenance Management System) module. This is a significant opportunity for industrial enterprises hoping to integrate and modernize their data acquisition and management systems while maintaining compliance with ISA-95.
As always, the new module is fully integrated into the Status Enterprise platform to ensure seamless integration with your information model and all alarms and notifications, workflow events and tasks, calculations, reports, and of course B-Scada's world-class visualization tools.
B-Scada has been fortunate to work with enterprises in numerous industrial verticals around the world - from small businesses to Fortune 500 brands and industry leaders. Status Enterprise has been deployed to solve a wide range of industrial and commercial problems in manufacturing, energy management, building automation, agriculture, finance, IT and more. Armed with these use cases and customer interactions, B-Scada continues to enhance the system with additional features that directly address the needs of users.
Status Enterprise 4.0 is scheduled for release on November 2, 2015.
re: deleted
The "Zelig of Wall Street" deemed too irrelevant and self-promoting for Wikipedia?
https://en.wikipedia.org/wiki/Terren_Peizer
I'm a little confused with XXII's relationship with him at this point.
Dr Rushton seems like the perfect hire for XXII. He is accomplished and an expert in the field of tobacco genomic research. A perfect fit.
Jonathan Page is an expert in the field of cannabis research, so looks like XXII has the tools in place for advancing research these fields.
Can anyone confirm that Page is still collaborating with XXII? I havent heard his name mentioned recently and Henry's comment about Rushton also spearheading the cannabis end of things had me wondering about Page (as I thought he was the man on that front). Thanks for any clarification.
“Paul’s experience will enable him to contribute immediately to the Company’s Modified Risk Tobacco Products in development and to spearhead our cannabis technology initiatives.”
Thanks for the correction. Looks like they represent 2 other companies (one trading at 14 cents and the other 38 cents-and one of the company names is misspelled on their website (Future Healthcare of Amercia)). I think its time for XXII to put on its big boy pants and act big/legitimate instead of dealing with these small-time penny stock promoters. JMO!
Nice gain today. I think people are starting to digest the ramifications of the NEJM study.
I am disappointed XXII is still paying penny stock promoters $20k for a pump piece geared towards day traders. There are already 2 separate IR firms representing XXII (for some reason) : Andrew Haag at IRTH and Tom Redington at Redington . Why is management continuing to allocate precious resources toward micro-cap newsletters geared towards day-traders when they could be hiring more Red Sun regional sales reps with that cash? The NEJM study, BAT, govt agencies studying Spectrum, MSA, interviews w/ Bonny, etc give me hope that XXII is entering prime time and ready to be taken seriously...but paying stock promoters instead of using cash to build fundamentals has me scratching my head. JMO
I am liking the recent news flow. Things seem to be picking up for Status Enterprise sales, especially in the foreign markets. Also, seems to be validation in government agencies trusting the platform to conduct operations. If its good enough for government agencies, it should be good enough for private businesses.
I wonder what a contract like this generates for revenue? I guess we will find out Q4 and into 2016.
Asian Market Continues to Embrace B-Scada
Tuesday, October 6, 2015
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has announced another important account secured by their trusted partner, Foreshow Information. The customer represents an important government agency in Taiwan. They will be deploying B-Scada's Status Enterprise platform to monitor and manage economic activity through custom dashboards.
Foreshow Information recommended Status Enterprise as an ideal solution. Status Enterprise allows users to consolidate and organize disparate data from numerous sources, creating a real-time network of communication and visualization that transforms business and production data into actionable real-time intelligence.
PR released in French yesterday evening. Next country to launch Magic?
http://ih.advfn.com/p.php?pid=nmona&article=68749419&symbol=XXII
another link to add
this sums up the results with an easy-to-follow video:
https://www.facebook.com/TheNewEnglandJournalofMedicine/videos/10153368536028462/
I found some additional articles relating to the study:
http://www.journalnow.com/business/business_news/local/davie-cigarette-maker-has-role-in-low-nicotine-study/article_e4d86e29-79c0-5cb6-afbf-537ef2c3a7df.html
http://www.buffalonews.com/city-region/study-hints-at-benefits-of-low-nicotine-in-cigarettes-20151002
http://www.medpagetoday.com/PrimaryCare/Smoking/53896
http://www.webmd.com/smoking-cessation/news/20150930/low-nicotine-cigarettes-may-help-smokers-quit (someone should tell Donny that the cigarettes he used for the study are not produced the way he thinks: "Tobacco companies already have the technology to mass-produce very low-nicotine cigarettes, Donny said, comparing it to the process that creates decaffeinated coffee.")
http://www.sci-tech-today.com/story.xhtml?story_id=0020001IW4N4
If "his end-game is to take over the company and run it himself," wouldn't "vengeance selling" weaken his voting power and influence over the company the more shares he sells? And wouldn't he be required to file w/ the SEC if he were, if fact, selling shares?
The New England Journal of Medicine Publishes Landmark Study Using 22nd Century’s Proprietary Very Low Nicotine Cigarettes
22nd Century Group, Inc. (AMEX:XXII)
22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco harm reduction, announced that The New England Journal of Medicine has published a special article describing a milestone study that used the Company’s proprietary SPECTRUM research cigarettes (N Engl J Med 2015; 373:1340-1349). The Center for the Evaluation of Nicotine in Cigarettes led the double-blind, parallel, randomized clinical trial involving 840 smokers at ten locations. The authors concluded that data from the study suggests, as compared with cigarettes of conventional nicotine content, 22nd Century’s proprietary low nicotine SPECTRUM cigarettes were “associated with reductions in smoking, nicotine exposure, and nicotine dependence, with minimal evidence of nicotine withdrawal, compensatory smoking, or serious adverse events.”
The study, which was funded by the National Institute on Drug Abuse (NIDA) and the U.S. Food and Drug Administration (FDA) Center for Tobacco Products, included six styles of 22nd Century’s SPECTRUM research cigarettes. The SPECTRUM cigarettes had nicotine contents ranging from 15.8 mg per gram of tobacco (similar to commercial brands) to 0.4 mg per gram (“very low nicotine”). The very low nicotine SPECTRUM cigarettes contain 95% less nicotine than conventional cigarettes. 22nd Century is the only company in the world capable of growing tobacco with such low nicotine content.
Researchers found that during the 6th and final week of the trial, participants who were assigned 22nd Century SPECTRUM cigarettes with 0.4 mg/g nicotine smoked fewer cigarettes per day (14.9) than those assigned to their usual brand (22.2). In fact, very low nicotine cigarettes were found to reduce exposure to, and dependence on, nicotine and to reduce cravings while adverse events were generally mild and similar among groups. Moreover, in the 30 days following the trial, smokers of very low nicotine cigarettes reported they attempted to quit smoking at a rate double that of participants who smoked cigarettes with 15.8 mg/gram nicotine (34.7% vs. 17%).
The study’s lead author, Dr. Eric Donny, explained in an article posted on usatoday.com, "The evidence is getting stronger that reducing nicotine reduces smoking and makes people less addicted to cigarettes and, in doing so, might make them more likely to quit." To further test this theory, 22nd Century’s proprietary SPECTRUM cigarettes are being used in a Phase III clinical study that follows 1,250 smokers for five months (ClinicalTrials.gov NCT02139930).
The results of previous studies using very low nicotine cigarettes have demonstrated a host of desirable outcomes including reduced smoking, reduced nicotine exposure, reduce nicotine dependence, increased abstinence, reduced exposure to toxicants and few adverse events with little evidence of withdrawal-related discomfort or safety concerns. Unlike “light” cigarettes (as previously labeled and marketed by conventional tobacco companies) which reduce machine-smoking nicotine yields by diluting the smoke rather than by reducing the nicotine content of the tobacco itself, very low nicotine cigarettes do not result in compensatory smoking.
In the past 8 years, the prospect of reducing the addictiveness of cigarettes has received renewed attention from numerous health organizations, including the Institute of Medicine, the World Health Organization (WHO) and the Office of the U.S. Surgeon General. The Tobacco Control Act, enacted in 2009, granted the FDA authority to set standards that reduce the nicotine content of all cigarettes sold in the United States.
“The current study by Donny and colleagues adds to a growing literature supporting the feasibility and potential benefits of a national nicotine reduction policy…” explained public health policy reform advocates, Drs. Michael Fiore and Timothy Baker in a companion article in the same issue of the NEJM. “Reducing the nicotine content of combustible tobacco to levels that will not sustain dependence seems to us to be the most promising regulatory policy option for preventing [at least] 20 million premature deaths.”
I think this is a new partnership: http://m2mworldnews.com/2015/09/16/60306-libelium-adds-new-cloud-options-to-build-the-industrial-iot-and-smart-cities/
B-Scada Continues to Expand Presence in Asia
Wednesday, September 30, 2015
CRYSTAL RIVER, FL: B-Scada, Inc. (OTCQB: SCDA) has announced that their trusted partner, Foreshow Information, has secured an important municipal account in Taiwan's capital city, Taipei, helping to improve the delivery of key resources to their citizens. B-Scada's software will be used to monitor, manage and optimize their operations using real-time data delivered through custom web interfaces.
With the help of Foreshow Information and other resale partners, B-Scada continues to stake out a large portion of the data visualization market in Taiwan and throughout Asia.
Management Commentary:
"We are finding that in markets not already completely saturated by competitive brands, consumers are still making buying decisions based on quality and value as opposed to name recognition. This is where B-Scada stands out, and why we expect our market share will continue to grow. Of course, it always helps to have knowledgeable and talented local partners like Foreshow Information."
B Scada should certainly ride the wave of IoT, as they have the platform to visualize and organize the data (and now sensors to monitor, as well).
Nice to see a mention of the latest news in their local newspaper:
http://www.chronicleonline.com/content/another-firm-adopts-b-scada-technology
Interesting to note that BAT's reduced risk presentation was right before XXII's
http://www.tsrcinfo.com/images/69th_TSRC_Preliminary_Program_09-02-15.pdf
22nd Century Presents Potential Reduced Exposure Tobacco Cigarettes at National Tobacco Science Research Conference
Today 9:04 AM ET (Business Wire)Print
22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco harm reduction, announced that on Monday, September 21, 2015, Dr. Michael Moynihan, the Company's Vice President of Research & Development, made a presentation and served on a panel of industry experts to discuss 22nd Century Group's proprietary Very Low Nicotine cigarettes and the Company's novel Low Tar-to-Nicotine Ratio cigarettes at the 69th Tobacco Science Research Conference (TSRC) held in Naples, Florida.
Titled "Very Low Nicotine Cigarettes and Low Tar-to-Nicotine Cigarettes as Potential Reduced Exposure Tobacco Products," Dr. Moynihan's presentation explained that because of the wide acceptance by current smokers (as demonstrated in numerous clinical trials), Very Low Nicotine tobacco cigarettes and Low Tar-to-Nicotine Ratio tobacco cigarettes show great promise in substantially reducing total smoke exposure for smokers in the United States and around the world.
The Company is preparing its "BRAND A" cigarettes containing 22nd Century's proprietary Very Low Nicotine tobacco for submission to the U.S. Food and Drug Administration (FDA) as a reduced exposure tobacco product. Exclusively made from 22nd Century's proprietary tobacco, "BRAND A" contains approximately 95% less nicotine than tobacco in leading U.S. cigarette brands. In a recently completed independent trial of 840 subjects (CENIC NCT01681875), smokers were provided over a six week period with their usual brand or with one of six experimental cigarettes with different nicotine content that were all produced by the Company. Smokers provided with cigarettes containing our proprietary Very Low Nicotine tobacco not only reduced their nicotine intake, but consumed fewer cigarettes per day than those smokers who were provided with their usual brand cigarettes. The Very Low Nicotine cigarette smokers had lower scores on several measures of nicotine dependence and reported more quit attempts during follow-up.
In 2016, the Company also plans to submit a Modified Risk Tobacco Product application to the FDA for the Company's "BRAND B," the worlds' Lowest Tar-to-Nicotine Ratio tobacco cigarette. Unlike "low tar" brands in the U.S. market (previously labeled as such before this descriptor was banned by the FDA), the nicotine yield of "BRAND B" is similar to popular full-flavor brands. Studies of smokers using Low Tar-to-Nicotine Ratio cigarettes have demonstrated that smoking behavior changes and the dose of smoke, including "tar," inhaled by the smoker is significantly reduced as compared to the smoke inhaled with conventional cigarettes. Specifically, compensatory smoking (e.g., more and/or larger puffs per cigarette) is greatly curtailed in Low Tar-to-Nicotine cigarettes.
"We are pleased that scientists, public health officials, and even our peers in the tobacco industry are beginning to recognize that 22nd Century's technology represents a true paradigm shift in the combustible tobacco products market," said Henry Sicignano, III, President and Chief Executive Officer of 22nd Century Group. "Without "additive-free" implied health claims, gimmicky filters, or any other scientifically questionable technology, we plan to introduce to the US market two extraordinary and proprietary combustible cigarettes that are irrefutably reduced exposure products. Consumers deserve such important options."